UCB SA (UCBJF)
| Previous close | 82.00 |
| Open | 82.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 82.00 - 82.00 |
| 52-week range | 68.30 - 122.90 |
| Volume | |
| Avg. volume | 196 |
| Market cap | 16.136B |
| Beta (5Y monthly) | 0.34 |
| PE ratio (TTM) | 18.04 |
| EPS (TTM) | 4.55 |
| Earnings date | N/A |
| Forward dividend & yield | 1.37 (1.73%) |
| Ex-dividend date | 29 Apr 2022 |
| 1y target est | N/A |
- GlobeNewswire
Praxis Precision Medicines and UCB Announce Epilepsy Research Collaboration
BOSTON, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company, and UCB (EURONEXT BRUSSELS: UCB), a global biopharmaceutical company, today announced a strategic collaboration, based upon Praxis’ PRAX-020 program, for the discovery of small molecule therapeutics as potential treatments of KCNT1 related epilepsies. “We are excited to partner with UCB, a global leader in epilepsy drug development, as we work together toward a n
- Zacks
Here's Why Momentum in UCB SA (UCBJF) Should Keep going
If you are looking for stocks that are well positioned to maintain their recent uptrend, UCB SA (UCBJF) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
- Zacks
What Makes UCB SA (UCBJF) a Good Fit for "Trend Investing"
UCB SA (UCBJF) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
